Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma

NCT02270034 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme (Grade IV) of Cerebellum

Interventions

DRUG: Crizotinib

Sponsor

Grupo Español de Investigación en Neurooncología

Collaborators

[object Object]